News about new drugs of interest, healthcare industry trends and more from Walgreens
2010 Annual Drug Trend Report
Industry trends for controlling prescription drug spend: The 2009 results are in, and Walgreens Health Initiatives delivered a single-digit prescription drug trend for the sixth year in a row. Download the 2010 drug trend report and learn more about how Walgreens provides client cost-savings and high-quality, patient-first healthcare.
Specialty Pharmacy State of the Industry
By 2011, specialty pharmacy will be a $100 billion industry. Now more than ever, providing top quality patient care while holding down escalating costs requires expertise, commitment and flexibility—that's what Walgreens offers you. Our report details practical solutions for navigating the ever-changing healthcare environment.
Walgreens Specialty Pharmacy Drug Pipeline Report—First Quarter 2012
Medications to watch: Vismodegib, Mulsevo® (semuloparin) and Tofacitinib
Limited Distribution Medication List (January 2012)
Some specialty medications are available only through select Walgreens Specialty pharmacies.
